1165-P: In Vitro Actions of a Novel Biguanide (BIG), NT1195, That Support Its Use in T2D
Sign Up to like & getrecommendations! Published in 2019 at "Diabetes"
DOI: 10.2337/db19-1165-p
Abstract: Metformin, a frontline treatment for T2D, is a BIG drug with low potency and limiting side effects. To overcome these limitations, we examined a compound library of 265 novel BIGs by screening these agents against… read more here.
Keywords: 1165 vitro; actions novel; metformin; support ... See more keywords